{"nct_id":"NCT00500071","title":"Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2007-06-28","start_date_type":"ACTUAL","primary_completion_date":"2008-01-02","primary_completion_date_type":"ACTUAL","completion_date":"2008-01-02","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["TAK"]}